Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06840028 · ClinicalTrials.gov registry record · NA

Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors

A NA study of Physical Activity and Physical Inactivity, sponsored by The University of Tennessee, Knoxville.

Recruiting
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT06840028: Recruiting NA study of Physical Activity and Physical Inactivity, sponsored by The University of Tennessee, Knoxville.

NCT06840028 is a NA study of Physical Activity and Physical Inactivity that is actively recruiting participants, run by The University of Tennessee, Knoxville. The registered enrollment target is 160 participants, below the 357-participant average among 131 other Physical Activity trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06840028, a NA study of Physical Activity and Physical Inactivity, is actively recruiting participants, sponsored by The University of Tennessee, Knoxville.

RECRUITING
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

Participation in regular physical activity is vital to a healthy lifestyle. Research has shown that regular participation in physical activity among cancer survivors is not only able to improve health outcomes, but is also related to their quality of life. As we live in an age of technology, health wearables and smartphone apps might be one novel manner by which to help cancer survivors increase physical activity as well as improve health outcomes. Yet, the effectiveness of wearable and app as a tool for health promotion among cancer survivors is largely unstudied. The purpose of this study is to evaluate the effectiveness of a personalized m-health intervention via fitness wearable (Fitbit Inspire 3) exercise app (sFitRx) on physical activity, weight, quality of life, individual beliefs, and emotions among cancer survivors.

Primary Outcome

Physical Activity. CS's mean steps/day will be the primary outcome and will be assessed using Fitbit Inspire. Participants will be instructed to wear the Fitbit on the non-dominant wrist at all times throughout the study.

Conditions Studied

Physical Activity Physical Inactivity Chronic Disease Cancer Survivors Cancer Survivorship Physical Activity in Adults

Interventions

  • OTHER mHealth/sFitRx
  • OTHER Fitness Tracker

Study Locations (1)

Tennessee

  • University of Tennessee Medical Center - Knoxville

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2025-03-01
Est. Completion 2026-03-01
Phase NA
The University of Tennessee, Knoxville

81 total trials

What NCT06840028 shows while recruiting

NCT06840028 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 357-participant average among 131 other Physical Activity trials with a reported enrollment target (55% lower).

The record links to 6 conditions, with Physical Activity appearing as the primary indexed condition, and to 2 interventions - of which mHealth/sFitRx is the first listed.

NCT06840028 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT06840028 about?

NCT06840028 is a clinical study titled "Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors". Participation in regular physical activity is vital to a healthy lifestyle. Research has shown that regular participation in physical activity among cancer survivors is not only able to improve health outcomes, but is also related to their quality of life. As we live in an age of technology, health...

What is the current status of trial NCT06840028?

This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2025-03-01. Estimated completion is 2026-03-01.

What conditions does trial NCT06840028 study?

This clinical trial studies the following conditions: Physical Activity, Physical Inactivity, Chronic Disease, Cancer Survivors, Cancer Survivorship.

What interventions are being tested in trial NCT06840028?

The interventions under investigation include: mHealth/sFitRx (OTHER), Fitness Tracker (OTHER).

Who is sponsoring clinical trial NCT06840028?

This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06840028 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Physical Activity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06840028's enrollment target sits among peer trials

160 57th of 131 higher than 75 of 131 other Physical Activity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Physical Activity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00501826 · 160 participants · Phase 2

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • NCT00932139 · 160 participants · NA

    Effect of Electro-Acupuncture on Blood Pressure

  • NCT00992901 · 160 participants · Early Phase 1

    Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

  • NCT01515527 · 160 participants · Phase 2

    Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06840028

Source: ClinicalTrials.gov NCT06840028, the US trial registry maintained by the National Library of Medicine. NCT06840028 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.